SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Samsung Bioepis Submits FDA Application for Keytruda Biosimilar SB27

Samsung Bioepis submitted a new drug application to the US FDA for its Keytruda biosimilar SB27.

Related stories